CSGP vs STRO
CoStar Group Inc (CSGP) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
CoStar Group Inc (CSGP) is a real estate services company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported CSGP revenue for 2024-12-31 was $2.74B. Net income was $138.7M. Revenue was up 11.5% from 2023-12-31 to 2024-12-31. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
CSGP currently screens at market cap $13.84B and trailing P/E 484.1. STRO currently screens at market cap $470.8M.
Not investment advice. Open the CSGP and STRO stock pages for the full models.
Not investment advice.